Metabolic and Transcriptomic Signatures of the Acute Psychological Stress Response in the Mouse Brain
Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea
KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea
KAIST Stem Cell Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea
Abstract
Acute stress response triggers various physiological responses such as energy mobilization to meet metabolic demands. However, the underlying molecular changes in the brain remain largely obscure. Here, we used a brief water avoidance stress (WAS) to elicit an acute stress response in mice. By employing RNA-sequencing and metabolomics profiling, we investigated the acute stress-induced molecular changes in the mouse whole brain. The aberrant expression of 60 genes was detected in the brain tissues of WAS-exposed mice. Functional analyses showed that the aberrantly expressed genes were enriched in various processes such as superoxide metabolism. In our global metabolomic profiling, a total of 43 brain metabolites were significantly altered by acute WAS. Metabolic pathways upregulated from WAS-exposed brain tissues relative to control samples included lipolysis, eicosanoid biosynthesis, and endocannabinoid synthesis. Acute WAS also elevated the levels of branched-chain amino acids, 5-aminovalerates, 4-hydroxy-nonenal-glutathione as well as mannose, suggesting complex metabolic changes in the brain. The observed molecular events in the present study provide a valuable resource that can help us better understand how acute psychological stress impacts neural functions.
Untitled section
Keywords: stress, brain, transcriptomics, metabolomics, metabolism
Article notes
Untitled section
Received 2023 Feb 16; Revised 2023 Mar 13; Accepted 2023 Mar 18; Collection date 2023 Mar.
1. Introduction
Stress is defined as the related reactions of the body that are triggered by various environmental factors, which can be traced back to the general adaptation syndrome proposed by Selye [1,2,3]. The acute stress (AS) response promotes the chances of survival by regulating an organism’s energy resources to meet the metabolic demands [4]. When the stressor has lessened, stress must be immediately managed to avoid stress-related pathological responses [5]. Remarkably, organisms can efficiently react to stressful conditions and maintain mental health, even in response to severe stressors [6,7,8]. However, stress overload potentially disrupts physiological homeostasis, damages certain brain areas, and can develop into many mental diseases such as depression, anxiety, and post-traumatic stress disorder (PTSD) [9,10,11].
Anatomical, physiological, and behavioral studies conducted over the past few decades have provided key insights into the mechanisms underlying stress-induced changes in the brain. For example, mood disorders have been linked to the hypothalamic–pituitary–adrenal cortex (HPA) axis dysregulation caused by stress [12]. Moreover, many studies have demonstrated that increases in glucocorticoid levels can affect the morphology and function of the brain [13,14,15]. Stress-induced changes in neurotransmitters, neuropeptides, and neurotrophic factors have also been widely reported in the brain [15,16,17]. Additionally, increases in the activity and synaptic plasticity of the amygdala are considered as another important driving factor of stress-induced mood disorders [18,19,20,21,22,23].
Several studies have explored stress-mediated molecular alterations in the brain [24,25,26,27,28,29,30,31,32,33]. Some studies have demonstrated transcriptional changes at different time points after stress challenge [25,34,35,36,37,38]. Other omics-based approaches (e.g., proteomics, metabolomics) have often been adopted to explore stress-linked molecular alterations in the brain. Various stress paradigms such as chronic social defeat stress, prenatal stress, and restraint have been used to identify molecular changes in different brain regions, classically associated with anxiety and depression-related behaviors including the prefrontal cortex, hippocampus, amygdala, and nucleus accumbens [33,39,40,41,42,43,44,45,46,47,48]. However, our knowledge on the biochemical and molecular changes occurring in the brain in response to acute stress remains largely insufficient.
Here, we employed a multi-omics approach in mice to identify core differentially expressed molecules and pathways underlying acute psychological stress. The acute water avoidance assay was used to induce anxiety-related phenotypes and to identify molecular markers and related pathways. Afterward, RNA-sequencing and metabolomics analyses were respectively conducted to detect differences in the gene expression and metabolite profiles of the whole brain of stress-exposed and control mice. Intriguingly, we detected alterations in metabolites and transcriptional reprogramming, providing insights into the genetic and metabolic changes linked to the psychological responses to acute stress.
2. Materials and Methods
2.1. Animals
C57BL/6J male mice were used for the experiments (8–10-week-old; KRIBB, Cheongju, Republic of Korea). Mice were housed under specific pathogen-free conditions in a 12 h light–dark schedule, and their food and water were provided ad libitum. Animal protocols were performed in accordance with guidelines approved by the Korea Advanced Institute of Science and Technology Animal Care and Use Committee.
2.2. Water Avoidance Stress Procedure
The 1 h water avoidance stress (WAS) procedure consisted of placing each mouse on a small platform (3 cm width × 5 cm length × 4 cm height) in the middle of a small plastic basin (40 cm length × 40 cm width × 60 cm height) filled with warm water (22 °C) at the height level of the platform. Control group mice were placed on the same platform but in a waterless container for 1 h. All animals were sacrificed immediately after completion of the stress procedure. After removing the olfactory bulbs and cerebellum, the whole forebrain was separated into two hemispheres. Each hemisphere was subject to RNA-Seq and metabolomics analysis.
2.3. Total RNA Extraction and RNA-Sequencing
Total RNA was isolated using Trizol reagent (Invitrogen, Waltham, MA, USA). RNA quality was assessed with an Agilent 2100 bioanalyzer using the RNA 6000 Nano Chip (Agilent Technologies, Santa Clara, CA, USA). RNA quantification was performed using an ND-2000 Spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA). QuantSeq 3′ mRNA-Seq was performed by Ebiogen (Ebiogen, Inc., Seoul, South Korea). The library of control and test RNAs were constructed by using the QuantSeq 3′ mRNA-Seq Library Prep Kit (Lexogen GmbH, Vienna, Austria) according to the manufacturer’s instructions. In brief, each prepared 500 ng total RNA were hybridized with an oligo-dT primer containing an Illumina-compatible sequence at its 5′ end. Then, reverse transcription was performed. After degradation of the RNA template, second strand synthesis was initiated by random primers with an Illumina-compatible linker sequence at the 5′ end. The double-stranded library was purified by removing all reaction components using magnetic beads. After the library was amplified to add the complete adapter sequences required for cluster generation, it was purified from the PCR components. High-throughput sequencing was performed as single-end 75 bp sequencing using NextSeq 500 (Illumina, Inc., San Diego, CA, USA).
QuantSeq 3′ mRNA-Seq reads were aligned using Bowtie2 [49]. Bowtie2 indices were generated from genome assembly sequences or representative transcript sequences for alignment to the genome and transcriptome. The alignment file was used to assemble transcripts, estimate their abundances, and detect differential gene expression. Based on counts from unique and multiple alignments using coverage in Bedtools [50], differentially expressed genes were determined. The RC (read count) data were processed based on the quantile normalization method using EdgeR within R (R Development Core Team, 2016) using Bioconductor [51]. Gene classification was based on searches conducted by the DAVID (http://david.ncifcrf.gov/ (accessed on 17 March 2023)) and Medline databases (http://www.ncbi.nlm.nih.gov/ (accessed on 17 March 2023)). Data mining and graphic visualization were performed using ExDEGA (Ebiogen Inc., Seoul, South Korea). A cutoff was applied at a normalized gene expression (log2) of 2. Sequencing data were deposited in the NCBI GEO (accession number GSE227416).
3. Results
3.1. Transcriptome Analysis of the Brain under Acute Stress
The water avoidance stress model was adopted to induce acute psychological stress, which strongly activates the sympathetic nervous system and the hypothalamic–pituitary–adrenal (HPA) axis. Adult male mice were subjected to water stress for 1 h at room temperature (Figure 1). To gain a deeper understanding of the molecular mechanisms occurring in the stress-exposed brain, forebrain tissues were used for RNA-Seq analyses. A total of only 60 (25 upregulated and 35 downregulated) differentially expressed genes (DEGs) were identified between the control and AS-exposed animals based on a fold change (FC) ≥1.5 for upregulation and ≤−1.5 for downregulation (Figure 2A and Supplementary Table S1). Once we had obtained a list of DEGs, GO enrichment analysis was conducted to clarify the biological functions in the mouse brain affected by acute water avoidance stress. We identified several modestly but significantly enriched GO categories including “regulation of transcription from RNA polymerase II promoter”, “negative regulation of chromatin silencing”, “superoxide anion generation”, “superoxide anion metabolism”, and “regulation of sodium ion transport” in the stress-exposed brain (Figure 2B,C). Downregulation of Nos1 (nitric oxide synthase 1, neuronal NOS) was notable since neuronal NOS catalyzes the synthesis of nitric oxide (NO), a potent neuromodulator, implying perturbed neuronal communication in response to acute WAS. Changes in regulatory Ncf1/p47phox and Noxo1 subunits in superoxide-generating NADPH oxidase also suggest the dysregulation of ROS metabolism under acute WAS.
3.2. Unique Alterations in a Broad Range of Metabolites in the Mouse Brain Exposed to Acute Water Avoidance Stress
To identify stress-induced metabolic changes, we next performed global untargeted metabolomics analysis and found that 43 metabolites out of the 407 identified in total were significantly different after 1 h of stress conditions (Figure 3A and Supplementary Table S2). Notably, the stress group displayed elevated levels of corticosterone, a representative stress biomarker belonging to the glucocorticoid class of steroid hormones [55], which explained the activation of the psychological stress response upon exposure to the water avoidance stress challenge (Figure 3B). Different metabolites in stressed brain samples fell into the following broad categories: lipid metabolism, endocannabinoid metabolism, amino acid metabolism, and additional miscellaneous categories.
3.3. Activation of Lipolysis and Eicosanoid Metabolic Pathways
When the stress group was compared to the control group, significant differences were mostly observed in lipid metabolism. Most notably, the stress group exhibited elevated levels of long-chain fatty acids and polyunsaturated fatty acids (PUFAs). In fact, 14 out of the 43 statistically significant differences between the stress and control groups involved these metabolites (Figure 4B,C). In addition to free fatty acids, lysolipids were markedly increased in the stressed brain tissues (Figure 4D). Lysolipids are formed when lipases in the cell remove fatty acid moieties from the Sn-1 or Sn-2 position of phospholipids [56]. Most of the lysolipids that were elevated in this study lacked acyl chains at the Sn-2 position and were derived from phosphatidylinositol (PI), phosphatidylserine (PS), and phosphatidylglycerol (PG). Taken together, these changes in lipid metabolites suggest that there was an increase in phospholipase A2 (PLA2) activity. PLA2 specifically cleaves fatty acids at the Sn-2 position. Unsaturated fats such as arachidonic acid are commonly found at the Sn-2 position of phospholipids. Therefore, increases in phospholipase A2 activity can result in arachidonate release and alterations in the eicosanoid signaling pathway [57]. The levels of two eicosanoid metabolites including prostaglandin F2alpha (PGF2alpha) and 15-hydroxyeicosatetraenoic acid (15-HETE) (Figure 5) were elevated in the brain of the stressed mice.
3.4. Acute Stress Elevates Endocannabinoid Levels in the Brain
Elevated levels of palmitoylethanolamide (PEA) and N-palmitoyl taurine were detected in the brains of the stressed animals (Figure 6). These metabolites are classified as endocannabinoids, which are lipid signaling molecules that regulate a wide range of physiological responses including mood, appetite, nociception, and memory [58]. PEA is reported to have anti-inflammatory and neuroprotective properties [59]. N-acyl taurines such as N-palmitoyl taurine are known to activate TRP receptors, which play diverse roles in processes such as mechanical transduction, osmotic regulation, and temperature sensing [60].
3.5. Changes in Amino Acid Metabolism
The stress-exposed group displayed elevated levels of all three branched-chain amino acids (BCAAs) including leucine, isoleucine, and valine (Figure 7). The changes in these amino acids reflect either increased protein breakdown within brain cells (e.g., neurons, glia) or increased uptake of amino acids into the brain from the bloodstream. Among other amino acid metabolites, significant increases in the lysine catabolite 5-aminovalerate were also found in stressed brain tissues (Figure 7), indicating alterations in the utilization, catabolism, or uptake of lysine.
3.6. Increased 4-Hydroxy-Nonenal-Glutathione Levels
Higher levels of 4-hydroxy-nonenal-glutathione were detected in the stress group (Figure 8). This metabolite is a glutathione conjugate of 4-hydroxy-2-nonenal (HNE), a major metabolite produced from the oxidation of n-6 PUFAs such as linoleic, γ-linolenic, or arachidonic acids [61]. HNE is known to react with a large number of macromolecules such as proteins, thus contributing to protein cross-linking and inducing carbonyl stress [61]. Given that 4-hydroxy-nonenal-glutathione is produced from the detoxification process, elevated 4-hydroxy-nonenal-glutathione can be interpreted as a metabolic signature of oxidative stress triggered by the acute water avoidance conditions.
3.7. Increased Mannose Levels
We found no apparent changes in the major metabolites from carbohydrate metabolism (e.g., glycolysis, TCA cycle, pentose phosphate pathway). The levels of other carbohydrates such as fructose, sorbitol, galactose 1-phosphate, and galactonate were similar between the control and acute stress samples. Interestingly, in contrast to the control brain, the brain tissues of the stressed mice exhibited a nearly 3-fold significant increase of mannose, but not its immediate downstream product, mannose 6-phosphate (Figure 9). This selective increase suggested that robust mannose uptake occurs in the brain during the early acute phase of psychological stress.
3.8. Integration Analysis of Transcriptomic and Metabolomic Data
Multiple-omics analysis profiling is a comprehensive approach that can significantly increase the strength of results, providing in-depth insights into the molecular mechanisms of biological phenomena compared to transcriptomic, proteomic, or metabolomic analyses alone [62]. Therefore, we used MetaboAnalyst 5.0 to perform the joint pathway analysis of transcriptomic and metabolomic data. The pathway analysis results with MetaboAnalyst 5.0 are shown in Supplementary Table S3. The mRNA enrichment and metabolic pathway analyses revealed significantly altered pathways at both the metabolomic and mRNA expression levels in the acute WAS-exposed mouse brain. Particularly, the dysregulated pathways were involved in the biosynthesis of unsaturated fatty acids, aminoacyl-tRNA biosynthesis, and glycerophospholipid metabolism, among other processes (Figure 10). Valine/leucine/isoleucine biosynthesis was the most impactful pathway showing the highest impact coefficients > 0.35, indicating that BCAA metabolism was dysregulated due to acute WAS treatment.
4. Discussion
The stress response is a vital biological function that is crucial for increasing the host’s chances of survival by coordinating energy homeostasis and various other physiological responses. Therefore, the host organism must control its stress levels to avoid the physiological disturbances that accompany chronic stress exposure. Furthermore, excessively intense or frequent stress can impair the homeostatic stress response, leading to the development of psychiatric conditions such as depression, anxiety, and PTSD [9,10,11]. Given the profound role of the brain as the central organ for stress sensing and response as well as the regulation of systemic stress, the goal of this study was to define the major molecular changes of stress-associated genes and metabolites in an unbiased manner. Previous rodent studies have been predominantly conducted under repeated or chronic stress conditions [27,28,32,36,39,42,43,47]. However, compared to our understanding of the effects of chronic stress, the impacts of acute stress (AS) on the brain remain largely unexplored. In addition to the duration of stress, various stressors engage different neuronal populations and circuits. Forced swimming, constraint, or social defeat models are commonly employed in stress response analysis. Here, we chose to focus on the water avoidance stress (WAS) response, a well-known animal assay that mimics the psychological changes in humans in response to environmental stressors.
In this study, 60 mRNAs changed significantly in the mouse brain in response to WAS exposure including 25 mRNAs that increased and 35 that decreased. In our analysis of differentially expressed mRNAs, regulation of transcription from RNA polymerase II promoter, negative regulation of chromatin silencing, superoxide anion metabolism, and the regulation of sodium ion transport were enriched. No genes related to energy metabolism were altered. Instead, levels of metabolic genes such as glutathione S-transferase mu6, Ncf1/p47phox, and Noxo1 were affected by acute WAS, indicating oxidative stress response upon acute WAS. Although there was no apparent change in well-known immediate early genes (e.g., c-jun, c-fos, psd95, homer), our data revealed that acute water avoidance stress regulates the expression of unique sets of genes (e.g., P2Y purinergic receptor, potassium voltage-gated channel subfamily H, member 7 (Kcnh7), neuronal NOS, IGF-BP) in pathways related to synaptic signaling and neuronal activities. Taken together with the altered mRNA levels of Doc2b and calcium binding protein 1 (CaBP1) responsible for calcium-sensitive neuronal activities, these findings clearly suggest potent changes in neuronal communication in stressed brain tissues. Acute WAS also made a robust impact on genes responsible for brain development and morphogenesis (e.g., Satb2, Hist1h1e, Npas1), suggesting the contribution of acute WAS to the accompanied neural defects.
In our analyses, the most striking molecular changes observed in the stress-exposed brain tissues were marked increases in the levels of n-3 and n-6 PUFAs (e.g., linolenate, eicosapentaenoate, and docosapentaenoate) as well as long-chain fatty acids such as palmitoleate and eicosenoate. No changes in the short and medium chain fatty acids were found between the control and stress groups. Furthermore, we found that lysophospholipids lacked acyl chains at the Sn-2 position, which constituted another major change in fatty acid metabolism. These findings strongly suggest that acute WAS conditions trigger the selective activation of PLA2 in the brain. PLA2 is a diverse group of enzymes including secretory PLA2 (sPLA2), cytosolic PLA2 (cPLA2), and calcium-independent PLA2 (iPLA2). In addition to neurotrophic and excitatory signals (e.g., glutamate), inflammatory cytokines are known to activate PLA2 and produce free fatty acids and lysophospholipids [63]. Particularly, the released arachidonic acid is metabolized into bioactive eicosanoids (prostaglandins, leukotrienes, thromboxanes), and lysophospholipids are converted into platelet-activating factors. As expected, the levels of PGF2alpha and 15-HETE were increased in the AS-exposed brain samples. These lipid mediators play critical roles in the initiation, maintenance, and modulation of inflammation and oxidative stress in the brain [64]. It should also be noted that lysophospholipids also act as potent bioactive signaling molecules by binding to their cognate receptors to mediate various cellular activation (e.g., proliferation, migration) and inflammation [56,65]. Another important outcome of PLA2 activation is the accumulation of reactive fatty acid metabolites, which lead to the generation of 4-hydroxy-2-nonenol (HNE). Elevated levels of 4-hydroxy-nonenal-glutathione were also found in the brains of the AS-exposed mice. Collectively, these metabolic signature profiles indicate that acute water avoidance stress stimulates PLA2 and the subsequent release of bioactive lipids (e.g., eicosanoids), which in turn triggers a wide range of signaling events (e.g., neuroinflammation), membrane structural damages, free radical generation, and cellular injury in the brain. Furthermore, there were no differences in the expression levels of PLA2 and other genes (e.g., lipoxygenase, cyclooxygenase) between the stressed and control groups, indicating that these metabolite changes are independent of the transcriptional regulation of the main catalytic enzymes. Similar to our findings, a previous study also reported PLA2 hyperactivation in the rat brain after four weeks of chronic unpredictable stress [66].
Endocannabinoid (eCB) signaling has been interpreted as a gatekeeper against stress and anxiety due to its modulatory role in the behavioral responses to environmental cues [58,67]. Under resting conditions, the eCB anandamide (N-arachidonoylethanolamine; AEA) appears to inhibit the activation of the brain (e.g., amygdala) and the hypothalamic–pituitary–adrenal axis. Glucocorticoid hormones secreted during stress start triggering an array of physiological adaptive events. Endocannabinoid signaling further sends feedback signals to modulate the activity of the hypothalamic–pituitary–adrenal (HPA) axis, which governs the secretion of glucocorticoids [68]. Exposure to acute stress has been known to rapidly reduce or elevate eCB in different brain regions in response to an array of psychological stressors. For example, in response to stressful stimuli, the amygdala shows dynamic changes in eCB levels, resulting in rapid AEA declines by increasing the activity of fatty acid amide hydrolase (FAAH), an AEA-hydrolyzing enzyme [69]. Many other studies have suggested that stress increases 2-arachidonoyl glycerol (2-AG) signaling [70,71]. Elevated levels of the two eCBs, palmitoyl ethanolamide (PEA) and N-palmitoyl taurine, were detected in the AS-exposed brain in our study, thus confirming the well-known cortisol-mediated neuronal activity induced by 1 h of acute WAS stimulation. These data suggest that hyperactive PLA2 metabolism and increased PUFAs (e.g., palmitate) are metabolically connected and contribute to the synthesis and activity of cortisol during the acute stress response.
Unexpectedly, energy and glucose metabolism such as glycolysis, TCA cycle, and oxidative phosphorylation remained unchanged in the brain after 1 h of acute WAS stimulation. The only unique and substantial result from carbohydrate metabolites is the nearly 3-fold increase in mannose levels but no other carbohydrates (e.g., fructose, sorbitol, galactose 1-phosphate, galactonate). Mannose, a C-2 epimer of glucose, is the major monosaccharide component of N-glycans and is internalized into mammalian cells via membrane glucose transporters. Upon its uptake into the cells, D-mannose is phosphorylated by hexokinase and produces mannose-6-phosphate (M6P), which can be directed into the glycolysis or glycosylation pathway. M6P metabolite levels were not altered by AS and our RNA-Seq analyses did not detect the expression of glucose transporter genes, suggesting that the marked increase in mannose levels observed in our study was likely caused by an increased uptake from the peripheral tissues. A previous study demonstrated that plasma concentrations of mannose were positively correlated with insulin resistance, and this effect was independent of the body mass index (BMI) [72]. Indeed, an elevated plasma mannose level is considered as a risk indicator for several metabolic diseases such as type 2 diabetes (T2D) and cardiovascular disease [73]. Therefore, future studies should investigate whether mannose levels can be used as biomarkers for other stress conditions, in addition to characterizing the physiological effects of mannose metabolism in the initiation, progress, and resolution of the stress response.
Finally, we identified several other metabolic changes (e.g., increased branched-chain amino acids (BCAA) and 5-aminovalerate) in the AS-exposed brain samples. BCAAs are key nitrogen donors in the glutamate/glutamine cycle. Within the central nervous system (CNS), glutamate, which is formed via BCAA transamination, is an excitatory neurotransmitter and substrate for the synthesis of the major inhibitory neurotransmitter GABA [74]. Current theories on the role of BCAAs in the brain are consistent with the involvement of glutamatergic and/or GABAergic systems in the etiology of neurological disorders. Fluctuations in BCAA levels significantly influence CNS function, particularly the balance between excitation and inhibition. BCAA metabolism contributes to the synthesis of new glutamate when this amino acid becomes depleted in the neurons in response to oxidative stress, and therefore, this process plays a crucial role in brain function homeostasis [75]. The levels of BCAA, leucine, isoleucine, and Val are decreased in patients suffering from psychiatric disorders such as major depressive disorder, immune-related major depression, and bipolar disorder [76,77,78]. BCAA levels are also elevated in the hippocampus after antidepressant treatment [79]. Furthermore, 5-aminovaleric acid, which is endogenously synthesized or derived from the metabolism of lysine by gut microbiota, is also known to act as a methylene homolog of gamma-aminobutyric acid (GABA) and functions as a weak GABA agonist [80]. Recently, 5-aminovaleric acid was identified in the plasma and brain tissues of Alzheimer’s disease patients [81]. It is currently unclear whether 5-aminovaleric acid could play a role in the stress response, presumably through synaptic modulation.
Our transcriptomic analyses identified a molecular profile that likely represents a short-term change in neural signaling and ROS metabolism. Overall, these gene expression changes demonstrate the weak relationship between the mRNA and metabolite levels. In turn, these findings suggest that there is increased regulation at an intermediate step between molecular events and metabolic reactions. As recently reported by von Ziegler et al. [33], the waves of increased and decreased transcriptional events upon acute WAS stimulation should be further investigated to fully understand the mechanisms through which the brain perceives acute stress and elicits homeostatic responses over time.
In conclusion, our study provides a detailed characterization of the molecular changes that occur in response to acute stress. Specifically, our study explored how a brief 1-h episode of water avoidance stress affected the transcription and metabolic profile of the brain in response to acute stress. Future studies will need to investigate region-specific changes using various omics technology platforms such as epigenomics and proteomics. Single-cell data with a higher temporal resolution will also be required to identify reliable stress biomarkers and gain insights into whether such molecular dysregulations could be associated with stress-related psychiatric disorders.
Acknowledgments
We thank all the members of the Kim lab for the discussion.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/metabo13030453/s1, Table S1: List of 60 DEGs in water avoidance stress (WAS) versus the control; Table S2: List of significantly altered brain metabolites in acute WAS versus the control; Table S3: Summary of joint pathway integration analysis of transcriptomic and metabolomic data with Metaboanalyst 5.0.
Institutional Review Board Statement
Ethics Committee Name: Korea Advanced Institute of Science and Technology Animal Care and Use Committee; Approval Code: KA2015-07; Approval Date: 2 April 2015.
Informed Consent Statement
Not applicable.
Data Availability Statement
Data available in a publicly accessible repository.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This work was supported by the National Research Foundation of Korea (NRF-2018R1A5A1024261, NRF-2013M3C7A1056102, and NRF-2020R1A2C3005765 to S.K.) and the KAIST Key Research Institutes Project (Interdisciplinary Research Group).
Footnotes
Footnote Group
References
Untitled section
References
- 1.Selye H. A Syndrome Produced by Diverse Nocuous Agents. Nature. 1936;138:32. doi: 10.1038/138032a0.
- 2.Selye H. The General Adaptation Syndrome and the Diseases of Adaptation. J. Clin. Endocrinol. 1946;6:117–230. doi: 10.1210/jcem-6-2-117.
- 3.Selye H. A Syndrome Produced by Diverse Nocuous Agents. J. Neuropsychiatry Clin. Neurosci. 1998;10:230a–231a. doi: 10.1176/jnp.10.2.230a.
- 4.Ulrich-Lai Y.M., Herman J.P. Neural Regulation of Endocrine and Autonomic Stress Responses. Nat. Rev. Neurosci. 2009;10:397–409. doi: 10.1038/nrn2647.
- 5.Sapolsky R.M. Why Stress Is Bad for Your Brain. Science. 1996;273:749–750. doi: 10.1126/science.273.5276.749.
- 6.McEwen B.S. Protective and Damaging Effects of Stress Mediators. N. Engl. J. Med. 1998;338:171–179. doi: 10.1056/NEJM199801153380307.
- 7.Bonanno G.A., Westphal M., Mancini A.D. Resilience to Loss and Potential Trauma. Annu. Rev. Clin. Psychol. 2011;7:511–535. doi: 10.1146/annurev-clinpsy-032210-104526.
- 8.Kalisch R., Baker D.G., Basten U., Boks M.P., Bonanno G.A., Brummelman E., Chmitorz A., Fernàndez G., Fiebach C.J., Galatzer-Levy I., et al. The Resilience Framework as a Strategy to Combat Stress-Related Disorders. Nat. Hum. Behav. 2017;1:784–790. doi: 10.1038/s41562-017-0200-8.
- 9.Tost H., Champagne F.A., Meyer-Lindenberg A. Environmental Influence in the Brain, Human Welfare and Mental Health. Nat. Neurosci. 2015;18:1421–1431. doi: 10.1038/nn.4108.
- 10.Godoy L.D., Rossignoli M.T., Delfino-Pereira P., Garcia-Cairasco N., de Lima Umeoka E.H. A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications. Front. Behav. Neurosci. 2018;12:127. doi: 10.3389/fnbeh.2018.00127.
- 11.McEwen B.S., Akil H. Revisiting the Stress Concept: Implications for Affective Disorders. J. Neurosci. 2020;40:12–21. doi: 10.1523/JNEUROSCI.0733-19.2019.
- 12.Stephens M.A.C., Wand G. Stress and the HPA Axis: Role of Glucocorticoids in Alcohol Dependence. Alcohol Res. Curr. Rev. 2012;34:468–483. doi: 10.35946/arcr.v34.4.11.
- 13.Pagliaccio D., Luby J.L., Bogdan R., Agrawal A., Gaffrey M.S., Belden A.C., Botteron K.N., Harms M.P., Barch D.M. Stress-System Genes and Life Stress Predict Cortisol Levels and Amygdala and Hippocampal Volumes in Children. Neuropsychopharmacology. 2014;39:1245–1253. doi: 10.1038/npp.2013.327.
- 14.Buss C., Davis E.P., Shahbaba B., Pruessner J.C., Head K., Sandman C.A. Maternal Cortisol over the Course of Pregnancy and Subsequent Child Amygdala and Hippocampus Volumes and Affective Problems. Proc. Natl. Acad. Sci. USA. 2012;109:E1312–E1319. doi: 10.1073/pnas.1201295109.
- 15.McEwen B.S., Nasca C., Gray J.D. Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex. Neuropsychopharmacology. 2016;41:3–23. doi: 10.1038/npp.2015.171.
- 16.Zhang X., Ge T.T., Yin G., Cui R., Zhao G., Yang W. Stress-Induced Functional Alterations in Amygdala: Implications for Neuropsychiatric Diseases. Front. Neurosci. 2018;12:367. doi: 10.3389/fnins.2018.00367.
- 17.Lakshminarasimhan H., Chattarji S. Stress Leads to Contrasting Effects on the Levels of Brain Derived Neurotrophic Factor in the Hippocampus and Amygdala. PLoS ONE. 2012;7:e30481. doi: 10.1371/journal.pone.0030481.
- 18.Christoffel D.J., Golden S.A., Russo S.J. Structural and Synaptic Plasticity in Stress-Related Disorders. Rev. Neurosci. 2011;22:535–549. doi: 10.1515/RNS.2011.044.
- 19.Ma H., Li C., Wang J., Zhang X., Li M., Zhang R., Huang Z., Zhang Y. Amygdala-Hippocampal Innervation Modulates Stress-Induced Depressive-like Behaviors through AMPA Receptors. Proc. Natl. Acad. Sci. USA. 2021;118:e2019409118. doi: 10.1073/pnas.2019409118.
- 20.Sumislawski J.J., Ramikie T.S., Patel S. Reversible Gating of Endocannabinoid Plasticity in the Amygdala by Chronic Stress: A Potential Role for Monoacylglycerol Lipase Inhibition in the Prevention of Stress-Induced Behavioral Adaptation. Neuropsychopharmacology. 2011;36:2750–2761. doi: 10.1038/npp.2011.166.
- 21.Douma E.H., de Kloet E.R. Stress-Induced Plasticity and Functioning of Ventral Tegmental Dopamine Neurons. Neurosci. Biobehav. Rev. 2020;108:48–77. doi: 10.1016/j.neubiorev.2019.10.015.
- 22.Aceto G., Colussi C., Leone L., Fusco S., Rinaudo M., Scala F., Green T.A., Laezza F., D’Ascenzo M., Grassi C. Chronic Mild Stress Alters Synaptic Plasticity in the Nucleus Accumbens through GSK3β-Dependent Modulation of Kv4. 2 Channels. Proc. Natl. Acad. Sci. USA. 2020;117:8143–8153. doi: 10.1073/pnas.1917423117.
- 23.Koo J.W., Wohleb E.S. How Stress Shapes Neuroimmune Function: Implications for the Neurobiology of Psychiatric Disorders. Biol. Psychiatry. 2021;90:74–84. doi: 10.1016/j.biopsych.2020.11.007.
- 24.Bagot R.C., Cates H.M., Purushothaman I., Lorsch Z.S., Walker D.M., Wang J., Huang X., Schlüter O.M., Maze I., Peña C.J. Circuit-Wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility. Neuron. 2016;90:969–983. doi: 10.1016/j.neuron.2016.04.015.
- 25.Gray J.D., Rubin T.G., Hunter R.G., McEwen B.S. Hippocampal Gene Expression Changes Underlying Stress Sensitization and Recovery. Mol. Psychiatry. 2014;19:1171–1178. doi: 10.1038/mp.2013.175.
- 26.Misiewicz Z., Iurato S., Kulesskaya N., Salminen L., Rodrigues L., Maccarrone G., Martins J., Czamara D., Laine M.A., Sokolowska E. Multi-Omics Analysis Identifies Mitochondrial Pathways Associated with Anxiety-Related Behavior. PLoS Genet. 2019;15:e1008358. doi: 10.1371/journal.pgen.1008358.
- 27.Cerniauskas I., Winterer J., de Jong J.W., Lukacsovich D., Yang H., Khan F., Peck J.R., Obayashi S.K., Lilascharoen V., Lim B.K. Chronic Stress Induces Activity, Synaptic, and Transcriptional Remodeling of the Lateral Habenula Associated with Deficits in Motivated Behaviors. Neuron. 2019;104:899–915. doi: 10.1016/j.neuron.2019.09.005.
- 28.Hamilton P.J., Chen E.Y., Tolstikov V., Peña C.J., Picone J.A., Shah P., Panagopoulos K., Strat A.N., Walker D.M., Lorsch Z.S. Chronic Stress and Antidepressant Treatment Alter Purine Metabolism and Beta Oxidation within Mouse Brain and Serum. Sci. Rep. 2020;10:18134. doi: 10.1038/s41598-020-75114-5.
- 29.Lepack A.E., Bagot R.C., Peña C.J., Loh Y.-H.E., Farrelly L.A., Lu Y., Powell S.K., Lorsch Z.S., Issler O., Cates H.M. Aberrant H3. 3 Dynamics in NAc Promote Vulnerability to Depressive-like Behavior. Proc. Natl. Acad. Sci. USA. 2016;113:12562–12567. doi: 10.1073/pnas.1608270113.
- 30.Peña C.J., Smith M., Ramakrishnan A., Cates H.M., Bagot R.C., Kronman H.G., Patel B., Chang A.B., Purushothaman I., Dudley J. Early Life Stress Alters Transcriptomic Patterning across Reward Circuitry in Male and Female Mice. Nat. Commun. 2019;10:5098. doi: 10.1038/s41467-019-13085-6.
- 31.Sun H., Damez-Werno D.M., Scobie K.N., Shao N.-Y., Dias C., Rabkin J., Koo J.W., Korb E., Bagot R.C., Ahn F.H. ACF Chromatin-Remodeling Complex Mediates Stress-Induced Depressive-like Behavior. Nat. Med. 2015;21:1146–1153. doi: 10.1038/nm.3939.
- 32.Wei J., Cheng J., Waddell N.J., Wang Z.-J., Pang X., Cao Q., Liu A., Chitaman J.M., Abreu K., Jasrotia R.S. DNA Methyltransferase 3A Is Involved in the Sustained Effects of Chronic Stress on Synaptic Functions and Behaviors. Cereb. Cortex. 2021;31:1998–2012. doi: 10.1093/cercor/bhaa337.
- 33.von Ziegler L.M., Floriou-Servou A., Waag R., Das Gupta R.R., Sturman O., Gapp K., Maat C.A., Kockmann T., Lin H.-Y., Duss S.N. Multiomic Profiling of the Acute Stress Response in the Mouse Hippocampus. Nat. Commun. 2022;13:1824. doi: 10.1038/s41467-022-29367-5.
- 34.Floriou-Servou A., von Ziegler L., Stalder L., Sturman O., Privitera M., Rassi A., Cremonesi A., Thöny B., Bohacek J. Distinct Proteomic, Transcriptomic, and Epigenetic Stress Responses in Dorsal and Ventral Hippocampus. Biol. Psychiatry. 2018;84:531–541. doi: 10.1016/j.biopsych.2018.02.003.
- 35.Roszkowski M., Manuella F., von Ziegler L., Durán-Pacheco G., Moreau J.-L., Mansuy I.M., Bohacek J. Rapid Stress-Induced Transcriptomic Changes in the Brain Depend on Beta-Adrenergic Signaling. Neuropharmacology. 2016;107:329–338. doi: 10.1016/j.neuropharm.2016.03.046.
- 36.Stankiewicz A.M., Goscik J., Majewska A., Swiergiel A.H., Juszczak G.R. The Effect of Acute and Chronic Social Stress on the Hippocampal Transcriptome in Mice. PLoS ONE. 2015;10:e0142195. doi: 10.1371/journal.pone.0142195.
- 37.Terenina E.E., Cavigelli S., Mormede P., Zhao W., Parks C., Lu L., Jones B.C., Mulligan M.K. Genetic Factors Mediate the Impact of Chronic Stress and Subsequent Response to Novel Acute Stress. Front. Neurosci. 2019;13:438. doi: 10.3389/fnins.2019.00438.
- 38.Tsolakidou A., Trümbach D., Panhuysen M., Pütz B., Deussing J., Wurst W., Sillaber I., Holsboer F., Rein T. Acute Stress Regulation of Neuroplasticity Genes in Mouse Hippocampus CA3 Area—Possible Novel Signalling Pathways. Mol. Cell. Neurosci. 2008;38:444–452. doi: 10.1016/j.mcn.2008.04.005.
- 39.Fan L., Yang L., Li X., Teng T., Xiang Y., Liu X., Jiang Y., Zhu Y., Zhou X., Xie P. Proteomic and Metabolomic Characterization of Amygdala in Chronic Social Defeat Stress Rats. Behav. Brain Res. 2021;412:113407. doi: 10.1016/j.bbr.2021.113407.
- 40.Zhang Y., Yuan S., Pu J., Yang L., Zhou X., Liu L., Jiang X., Zhang H., Teng T., Tian L. Integrated Metabolomics and Proteomics Analysis of Hippocampus in a Rat Model of Depression. Neuroscience. 2018;371:207–220. doi: 10.1016/j.neuroscience.2017.12.001.
- 41.Dulka B.N., Bourdon A.K., Clinard C.T., Muvvala M.B.K., Campagna S.R., Cooper M.A. Metabolomics Reveals Distinct Neurochemical Profiles Associated with Stress Resilience. Neurobiol. Stress. 2017;7:103–112. doi: 10.1016/j.ynstr.2017.08.001.
- 42.Xu Q., Jiang M., Gu S., Zhang X., Feng G., Ma X., Xu S., Wu E., Huang J.H., Wang F. Metabolomics Changes in Brain-Gut Axis after Unpredictable Chronic Mild Stress. Psychopharmacology. 2022;239:729–743. doi: 10.1007/s00213-021-05958-w.
- 43.Gao Y., Mu J., Xu T., Linghu T., Zhao H., Tian J., Qin X. Metabolomic Analysis of the Hippocampus in a Rat Model of Chronic Mild Unpredictable Stress-Induced Depression Based on a Pathway Crosstalk and Network Module Approach. J. Pharm. Biomed. Anal. 2021;193:113755. doi: 10.1016/j.jpba.2020.113755.
- 44.Zhang H., He W., Huang Y., Zeng Z., Yang X., Huang H., Wen J., Cao Y., Sun H. Hippocampal Metabolic Alteration in Rat Exhibited Susceptibility to Prenatal Stress. J. Affect. Disord. 2019;259:458–467. doi: 10.1016/j.jad.2019.08.002.
- 45.Shi B., Tian J., Xiang H., Guo X., Zhang L., Du G., Qin X. A 1H-NMR Plasma Metabonomic Study of Acute and Chronic Stress Models of Depression in Rats. Behav. Brain Res. 2013;241:86–91. doi: 10.1016/j.bbr.2012.11.036.
- 46.Lo Iacono L., Valzania A., Visco-Comandini F., Viscomi M.T., Felsani A., Puglisi-Allegra S., Carola V. Regulation of Nucleus Accumbens Transcript Levels in Mice by Early-Life Social Stress and Cocaine. Neuropharmacology. 2016;103:183–194. doi: 10.1016/j.neuropharm.2015.12.011.
- 47.Li X., Zhou X., Teng T., Fan L., Liu X., Xiang Y., Jiang Y., Xie P., Zhu D. Multi-Omics Analysis of the Amygdala in a Rat Chronic Unpredictable Mild Stress Model of Depression. Neuroscience. 2021;463:174–183. doi: 10.1016/j.neuroscience.2021.03.031.
- 48.Sillivan S.E., Jones M.E., Jamieson S., Rumbaugh G., Miller C.A. Bioinformatic Analysis of Long-Lasting Transcriptional and Translational Changes in the Basolateral Amygdala Following Acute Stress. PLoS ONE. 2019;14:e0209846. doi: 10.1371/journal.pone.0209846.
- 49.Langmead B., Salzberg S.L. Fast Gapped-Read Alignment with Bowtie 2. Nat. Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923.
- 50.Quinlan A.R., Hall I.M. BEDTools: A Flexible Suite of Utilities for Comparing Genomic Features. Bioinformatics. 2010;26:841–842. doi: 10.1093/bioinformatics/btq033.
- 51.Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J. Bioconductor: Open Software Development for Computational Biology and Bioinformatics. Genome Biol. 2004;5:R80. doi: 10.1186/gb-2004-5-10-r80.
- 52.Evans A.M., Bridgewater B.R., Liu Q., Mitchell M.W., Robinson R.J., Dai H., Stewart S.J., DeHaven C.D., Miller L.A.D. High Resolution Mass Spectrometry Improves Data Quantity and Quality as Compared to Unit Mass Resolution Mass Spectrometry in High-Throughput Profiling Metabolomics. Metabolomics. 2014;4:1.
- 53.Schrimpe-Rutledge A.C., Codreanu S.G., Sherrod S.D., McLean J.A. Untargeted Metabolomics Strategies—Challenges and Emerging Directions. J. Am. Soc. Mass Spectrom. 2016;27:1897–1905. doi: 10.1007/s13361-016-1469-y.
- 54.Evans A.M., DeHaven C.D., Barrett T., Mitchell M., Milgram E. Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems. Anal. Chem. 2009;81:6656–6667. doi: 10.1021/ac901536h.
- 55.Dhama K., Latheef S.K., Dadar M., Samad H.A., Munjal A., Khandia R., Karthik K., Tiwari R., Yatoo M.I., Bhatt P. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Front. Mol. Biosci. 2019;6:91. doi: 10.3389/fmolb.2019.00091.
- 56.Tan S.T., Ramesh T., Toh X.R., Nguyen L.N. Emerging Roles of Lysophospholipids in Health and Disease. Prog. Lipid Res. 2020;80:101068. doi: 10.1016/j.plipres.2020.101068.
- 57.Dennis E.A. Phospholipase A2 in Eicosanoid Generation. Am. J. Respir. Crit. Care Med. 2000;161:S32–S35. doi: 10.1164/ajrccm.161.supplement_1.ltta-7.
- 58.Mechoulam R., Parker L.A. The Endocannabinoid System and the Brain. Annu. Rev. Psychol. 2013;64:21–47. doi: 10.1146/annurev-psych-113011-143739.
- 59.Raso G.M., Russo R., Calignano A., Meli R. Palmitoylethanolamide in CNS Health and Disease. Pharmacol. Res. 2014;86:32–41. doi: 10.1016/j.phrs.2014.05.006.
- 60.Connor M., Vaughan C.W., Vandenberg R.J. N-Acyl Amino Acids and N-acyl Neurotransmitter Conjugates: Neuromodulators and Probes for New Drug Targets. Br. J. Pharmacol. 2010;160:1857–1871. doi: 10.1111/j.1476-5381.2010.00862.x.
- 61.Csala M., Kardon T., Legeza B., Lizák B., Mandl J., Margittai É., Puskás F., Száraz P., Szelényi P., Bánhegyi G. On the Role of 4-Hydroxynonenal in Health and Disease. Biochim. Biophys. Acta BBA-Mol. Basis Dis. 2015;1852:826–838. doi: 10.1016/j.bbadis.2015.01.015.
- 62.Pang Z., Zhou G., Ewald J., Chang L., Hacariz O., Basu N., Xia J. Using MetaboAnalyst 5.0 for LC–HRMS Spectra Processing, Multi-Omics Integration and Covariate Adjustment of Global Metabolomics Data. Nat. Protoc. 2022;17:1735–1761. doi: 10.1038/s41596-022-00710-w.
- 63.Farooqui A.A., Yang H., Rosenberger T.A., Horrocks L.A. Phospholipase A2 and Its Role in Brain Tissue. J. Neurochem. 1997;69:889–901. doi: 10.1046/j.1471-4159.1997.69030889.x.
- 64.Tassoni D., Kaur G., Weisinger R., Sinclair A. The Role of Eicosanoids in the Brain. Asia Pac. J. Clin. Nutr. 2008;17:220–228.
- 65.Gaire B.P., Choi J.-W. Critical Roles of Lysophospholipid Receptors in Activation of Neuroglia and Their Neuroinflammatory Responses. Int. J. Mol. Sci. 2021;22:7864. doi: 10.3390/ijms22157864.
- 66.Oliveira T.G., Chan R.B., Bravo F.V., Miranda A., Silva R.R., Zhou B., Marques F., Pinto V., Cerqueira J.J., Di Paolo G. The Impact of Chronic Stress on the Rat Brain Lipidome. Mol. Psychiatry. 2016;21:80–88. doi: 10.1038/mp.2015.14.
- 67.Morena M., Patel S., Bains J.S., Hill M.N. Neurobiological Interactions between Stress and the Endocannabinoid System. Neuropsychopharmacology. 2016;41:80–102. doi: 10.1038/npp.2015.166.
- 68.Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output. J. Neurosci. 2010;30:14980–14986. doi: 10.1523/JNEUROSCI.4283-10.2010.
- 69.Gray J.M., Vecchiarelli H.A., Morena M., Lee T.T.Y., Hermanson D.J., Kim A.B., McLaughlin R.J., Hassan K.I., Kühne C., Wotjak C.T., et al. Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety. J. Neurosci. 2015;35:3879 LP–3892 LP. doi: 10.1523/JNEUROSCI.2737-14.2015.
- 70.Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala. Neuropsychopharmacology. 2009;34:2699–2709. doi: 10.1038/npp.2009.101.
- 71.Rademacher D.J., Meier S.E., Shi L., Ho W.-S.V., Jarrahian A., Hillard C.J. Effects of Acute and Repeated Restraint Stress on Endocannabinoid Content in the Amygdala, Ventral Striatum, and Medial Prefrontal Cortex in Mice. Neuropharmacology. 2008;54:108–116. doi: 10.1016/j.neuropharm.2007.06.012.
- 72.Lee S., Zhang C., Kilicarslan M., Piening B.D., Bjornson E., Hallström B.M., Groen A.K., Ferrannini E., Laakso M., Snyder M. Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance. Cell Metab. 2016;24:172–184. doi: 10.1016/j.cmet.2016.05.026.
- 73.Mardinoglu A., Stančáková A., Lotta L.A., Kuusisto J., Boren J., Blüher M., Wareham N.J., Ferrannini E., Groop P.H., Laakso M. Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease. Cell Metab. 2017;26:281–283. doi: 10.1016/j.cmet.2017.07.006.
- 74.Fernstrom J.D. Branched-Chain Amino Acids and Brain Function. J. Nutr. 2005;135:1539S–1546S. doi: 10.1093/jn/135.6.1539S.
- 75.Yudkoff M. Interactions in the Metabolism of Glutamate and the Branched-Chain Amino Acids and Ketoacids in the CNS. Neurochem. Res. 2017;42:10–18. doi: 10.1007/s11064-016-2057-z.
- 76.Baranyi A., Amouzadeh-Ghadikolai O., von Lewinski D., Rothenhäusler H.-B., Theokas S., Robier C., Mangge H., Reicht G., Hlade P., Meinitzer A. Branched-Chain Amino Acids as New Biomarkers of Major Depression-a Novel Neurobiology of Mood Disorder. PLoS ONE. 2016;11:e0160542. doi: 10.1371/journal.pone.0160542.
- 77.Baranyi A., Meinitzer A., Rothenhäusler H.-B., Amouzadeh-Ghadikolai O., Lewinski D.V., Breitenecker R.J., Herrmann M. Metabolomics Approach in the Investigation of Depression Biomarkers in Pharmacologically Induced Immune-Related Depression. PLoS ONE. 2018;13:e0208238. doi: 10.1371/journal.pone.0208238.
- 78.Fellendorf F.T., Platzer M., Pilz R., Rieger A., Kapfhammer H.-P., Mangge H., Dalkner N., Zelzer S., Meinitzer A., Birner A. Branched-Chain Amino Acids Are Associated with Metabolic Parameters in Bipolar Disorder. World J. Biol. Psychiatry. 2019;20:821–826. doi: 10.1080/15622975.2018.1487077.
- 79.Webhofer C., Gormanns P., Tolstikov V., Zieglgänsberger W., Sillaber I., Holsboer F., Turck C.W. Metabolite Profiling of Antidepressant Drug Action Reveals Novel Drug Targets beyond Monoamine Elevation. Transl. Psychiatry. 2011;1:e58. doi: 10.1038/tp.2011.56.
- 80.Callery P.S., Geelhaar L.A. 1-Piperideine as an In Vivo Precursor of the Γ-Aminobutyric Acid Homologue 5-Aminopentanoic Acid. J. Neurochem. 1985;45:946–948. doi: 10.1111/j.1471-4159.1985.tb04085.x.
- 81.Kalecký K., German D.C., Montillo A.A., Bottiglieri T. Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites. J. Alzheimer’s Dis. 2022;86:1875. doi: 10.3233/JAD-215448.
Associated Data
Supplementary Materials
Data Availability Statement
Data available in a publicly accessible repository.